CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mebiopharm Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mebiopharm Co Ltd
8F, ARK Hills Executive Tower
1-14-5, Akasaka
Phone: +81 364265766p:+81 364265766 MINATO-KU, TKY  107-0052  Japan Ticker: 45804580
Business Summary
Mebiopharm Co Ltd operates as a pharmaceutical company that uses its technologies to develop new chemical entities with active targeting function specialized in Oncology. The Company develops medicine for the treatment of cancer and chronic inflammatory diseases.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20133/31/2011Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Representative Director TadashiFujisawa 53 7/1/2002 7/1/2002
Chief Director of Business Administration, Director NaoyukiMorisaki 51 7/1/2008 6/1/2008
Director of Medicine Research, Director KazushiOkada 37 10/1/2007 3/1/2006
Independent Director KazuoMaruyama 60 7/1/2002 7/1/2002

General Information
Number of Employees: 10 (As of 5/31/2011)
Outstanding Shares: 3,275,800 (As of 3/31/2013)
Stock Exchange: TYO
Fax Number: +81 335052663


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023